Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.36 USD | +0.01% | +0.04% | +8.22% |
16/05 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
16/05 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.22% | 3.44B | |
+13.69% | 130B | |
-17.54% | 7.37B | |
+46.41% | 5.87B | |
-33.08% | 4.1B | |
-19.90% | 2.47B | |
-16.33% | 1.94B | |
-24.61% | 1.72B | |
-36.56% | 1.51B | |
-17.74% | 1.05B |
- Stock Market
- Equities
- AXNX Stock
- News Axonics, Inc.
- Axonics Q4 Earnings, Revenue Rise -- Shares Edge Higher After Hours